Division of Hematology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden; and Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):587-591. doi: 10.1182/hematology.2021000294.
Infections are a major cause of morbidity and can result in mortality in long-term survivors after allogeneic hematopoietic cell transplantation. Chronic graft-versus-host disease and delayed immune reconstitution are recognized risk factors. Different strategies must be utilized depending on the individual patient's situation but include prolonged antimicrobial prophylaxis and vaccination. Some important infections due to pathogens preventable by vaccination are pneumococci, influenza, varicella-zoster virus, and SARS-CoV-2. Despite the fact that such recommendations have been in place for decades, implementation of these recommendations has been reported to be poor.
感染是导致发病率的主要原因,并且在异基因造血细胞移植后长期存活的患者中可导致死亡。慢性移植物抗宿主病和延迟的免疫重建是公认的危险因素。必须根据个体患者的情况使用不同的策略,但包括延长抗菌预防和疫苗接种。一些可通过疫苗预防的重要病原体感染包括肺炎球菌、流感、水痘带状疱疹病毒和 SARS-CoV-2。尽管这些建议已经存在了几十年,但据报道,这些建议的实施情况很差。